NYSE International 100
|
9 479,98
|
74,36
|
0,79 %
|
Analysen zu NYSE International 100-Werten
| 31.01.24 | Santander Halten | DZ BANK | |
| 31.01.24 | Santander Sector Perform | RBC Capital Markets | |
| 31.01.24 | Allianz Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | BBVA Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.01.24 | GSK Buy | UBS AG | |
| 31.01.24 | BBVA Buy | UBS AG | |
| 31.01.24 | Novartis Buy | UBS AG | |
| 31.01.24 | Santander Buy | UBS AG | |
| 31.01.24 | AstraZeneca Sell | UBS AG | |
| 31.01.24 | Diageo Overweight | Barclays Capital | |
| 31.01.24 | BBVA Overweight | Barclays Capital | |
| 31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Diageo Sell | UBS AG | |
| 31.01.24 | Diageo Outperform | Bernstein Research | |
| 31.01.24 | Diageo Sell | Deutsche Bank AG | |
| 31.01.24 | Nokia Buy | Deutsche Bank AG | |
| 31.01.24 | Vodafone Group Buy | Deutsche Bank AG | |
| 31.01.24 | BBVA Buy | Deutsche Bank AG | |
| 31.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 31.01.24 | Santander Neutral | JP Morgan Chase & Co. | |
| 31.01.24 | Mercedes-Benz Group Outperform | RBC Capital Markets | |
| 31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 31.01.24 | Diageo Hold | Jefferies & Company Inc. | |
| 30.01.24 | BBVA Overweight | JP Morgan Chase & Co. | |
| 30.01.24 | Sanofi Buy | UBS AG | |
| 30.01.24 | Novartis Buy | UBS AG | |
| 30.01.24 | GSK Buy | UBS AG | |
| 30.01.24 | Philips Overweight | Barclays Capital | |
| 30.01.24 | Diageo Overweight | Barclays Capital | |
| 30.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 30.01.24 | Diageo Sell | UBS AG | |
| 30.01.24 | Diageo Outperform | Bernstein Research | |
| 30.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.01.24 | Philips Sell | Deutsche Bank AG | |
| 30.01.24 | Diageo Underperform | RBC Capital Markets | |
| 30.01.24 | Diageo Sell | UBS AG | |
| 30.01.24 | BBVA Buy | UBS AG | |
| 30.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.01.24 | BBVA Overweight | JP Morgan Chase & Co. |